Tcr2 Therapeutics Correlations

Summary

TCRRDelisted Stock

USD 1.48 0.00 0.00%

The current 90-days correlation between Tcr2 Therapeutics and Affimed NV is -0.11 (i.e., Good diversification). The correlation of Tcr2 Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Tcr2 Therapeutics Correlation With Market

Very good diversification

The correlation between Tcr2 Therapeutics and DJI is -0.24 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Moving together with Tcr2 Stock

0.64	SSNLF	Samsung Electronics	Pair Corr
0.7	CSCO	Cisco Systems Aggressive Push	Pair Corr

Moving against Tcr2 Stock

0.9	EC	Ecopetrol SA ADR	Pair Corr
0.73	KO	Coca Cola Sell-off Trend	Pair Corr
0.64	TLK	Telkom Indonesia Tbk	Pair Corr
0.63	BKRKY	Bank Rakyat	Pair Corr
0.61	BA	Boeing Fiscal Year End 29th of January 2025	Pair Corr
0.6	PPERF	Bank Mandiri Persero	Pair Corr
0.57	PPERY	Bank Mandiri Persero	Pair Corr
0.54	PG	Procter Gamble	Pair Corr
0.52	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.51	BKRKF	PT Bank Rakyat	Pair Corr
0.45	MMM	3M Company Fiscal Year End 28th of January 2025	Pair Corr

Related Correlations Analysis

	AFMD	PIRS	ADCT	AGEN	RVMD	BDTX	BCEL	PASG	HARP	ALEC
AFMD		0.49	0.44	0.55	-0.45	0.76	-0.31	0.66	-0.5	0.71	AFMD
PIRS	0.49		0.2	0.45	-0.45	0.56	-0.23	0.58	-0.62	0.25	PIRS
ADCT	0.44	0.2		0.69	-0.46	0.37	0.21	0.4	-0.26	0.68	ADCT
AGEN	0.55	0.45	0.69		-0.83	0.78	0.15	0.73	-0.45	0.61	AGEN
RVMD	-0.45	-0.45	-0.46	-0.83		-0.8	-0.11	-0.55	0.56	-0.34	RVMD
BDTX	0.76	0.56	0.37	0.78	-0.8		-0.23	0.76	-0.63	0.52	BDTX
BCEL	-0.31	-0.23	0.21	0.15	-0.11	-0.23		-0.13	0.4	-0.17	BCEL
PASG	0.66	0.58	0.4	0.73	-0.55	0.76	-0.13		-0.47	0.46	PASG
HARP	-0.5	-0.62	-0.26	-0.45	0.56	-0.63	0.4	-0.47		-0.33	HARP
ALEC	0.71	0.25	0.68	0.61	-0.34	0.52	-0.17	0.46	-0.33		ALEC
	AFMD	PIRS	ADCT	AGEN	RVMD	BDTX	BCEL	PASG	HARP	ALEC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BDTX	+ 0.78	AGEN
BDTX	+ 0.76	AFMD
PASG	+ 0.76	BDTX
PASG	+ 0.73	AGEN
ALEC	+ 0.71	AFMD
AGEN	+ 0.69	ADCT

High negative correlations

RVMD	- 0.83	AGEN
BDTX	- 0.8	RVMD
HARP	- 0.63	BDTX
HARP	- 0.62	PIRS
PASG	- 0.55	RVMD
HARP	- 0.5	AFMD

Risk-Adjusted Indicators

There is a big difference between Tcr2 Stock performing well and Tcr2 Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tcr2 Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AFMD	2.71	(0.69)	0.00	(0.34)	0.00	0.00	7.25	(6.82)	21.26
PIRS	1.58	(0.14)	0.00	(0.10)	0.00	0.00	3.23	(3.40)	12.92
ADCT	3.40	(0.64)	0.00	(0.16)	0.00	0.00	6.98	(7.81)	22.87
AGEN	3.78	(0.95)	0.00	(0.19)	0.00	0.00	6.59	(8.60)	27.05
RVMD	2.00	0.34	0.15	0.41	2.02	(2.17)	4.81	(3.24)	10.95
BDTX	3.53	(1.50)	0.00	(0.59)	0.00	0.00	5.47	(8.30)	19.51
BCEL	3.90	0.26	0.01	(0.38)	5.00	(4.64)	7.53	(9.65)	23.80
PASG	5.09	(0.25)	(0.01)	0.02	5.96	(5.86)	10.00	(10.45)	25.50
HARP	3.55	0.54	0.11	4.89	3.28	(5.07)	9.59	(6.25)	22.48
ALEC	4.75	(1.18)	0.00	(0.29)	0.00	0.00	8.66	(8.42)	44.59

Tcr2 Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tcr2 Therapeutics stock to make a market-neutral strategy. Peer analysis of Tcr2 Therapeutics could also be used in its relative valuation, which is a method of valuing Tcr2 Therapeutics by comparing valuation metrics with similar companies.

Affimed NV Pieris Pharmaceuticals ADC Therapeutics SA Agenus Inc Revolution Medicines Black Diamond Therapeutics Atreca Inc Passage Bio Harpoon Therapeutics Alector Homology Medicines Stoke Therapeutics American Airlines Group Alcoa Corp Apple Inc

Risk & Return

Correlation

Tcr2 Therapeutics Corporate Management

Angela Justice	Chief Officer	Profile
Patrick Baeuerle	Founder Board	Profile
Richard Roomberg	VP Controller	Profile
Dr MBA	CEO Pres	Profile
Margaret JD	Head Sec	Profile
Rosemary Harrison	Chief Officer	Profile
Peter Olagunju	Chief Officer	Profile

Still Interested in Tcr2 Therapeutics?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC